Murielle Lortie

Murielle Lortie, CA, serves as the Chief Financial & Operating Officer and Chief Financial Officer at Claridge Inc. since September 2021. Lortie is also a Board Director at Profound Medical Inc. since November 2020. Prior to that, Lortie was the Chief Financial Officer at Liminal BioSciences from September 2018 to September 2021, overseeing all finance operations for a clinical-stage biopharmaceutical company. Lortie has held key financial roles at Cirque du Soleil Entertainment Group, Pharmascience, Bellus Health, Bristol-Myers Squibb Co., Lafarge, and Arthur Andersen, demonstrating extensive experience in financial management, strategic planning, mergers and acquisitions, and team leadership. Lortie holds a Chartered Accountant designation and has completed management development training at Duke University, and has earned degrees in Accountancy and Business Administration.